Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes

Exenatide is a GLP-1 receptor agonist approved for use in type 2 diabetes mellitus. In clinical trials, significant reductions in serum glucose and weight were demonstrated for exenatide with primary glycemic effects of the twice daily formulation on prandial glucose control. In this paper, we review recent research with exenatide as adjunctive therapy in type 2 diabetes mellitus. In particular, studies demonstrate ongoing benefit on glycemic control and weight reduction with continued therapy up to 82 weeks duration and efficacy as adjunctive therapy for patients taking metformin, thiazolidinediones, and/or a sulfonylurea and as compared to sitagliptin and various insulin formulations. Compared to insulin, exenatide likely has greatest benefit for those patients who are overweight or who need improved prandial glucose control. The new long-acting release formulation of exenatide has demonstrated slightly improved efficacy compared to the twice daily formulation as well as a reduction in gastrointestinal side effects. Emerging research is further exploring novel benefits of exenatide as adjunctive DM therapy, effects on prandial glycemic control, markers of hepatic inflammation, alternative dosage forms including intra-nasal administration, and effects on beta cell function

Interprofessional collaboration: three best practice models of interprofessional education

Interprofessional education is a collaborative approach to develop healthcare students as future interprofessional team members and a recommendation suggested by the Institute of Medicine. Complex medical issues can be best addressed by interprofessional teams. Training future healthcare providers to work in such teams will help facilitate this model resulting in improved healthcare outcomes for patients. In this paper, three universities, the Rosalind Franklin University of Medicine and Science, the University of Florida and the University of Washington describe their training curricula models of collaborative and interprofessional education

The Impact of Diabetes Concentration Programs on Pharmacy Graduates' Provision of Diabetes Care Services

Objective. To determine practice outcomes associated with doctor of pharmacy (PharmD) graduates from 2 universities who completed a diabetes-concentration

Strengthening Pharmaceutical Care Education in Ethiopia Through Instructional Collaboration

Objective. To describe the development, implementation, and initial outcomes of a pharmaceutical care training-of-trainers course developed to assist Ethiopian pharmacy faculty members and graduate students in the development of curriculum and provision of pharmaceutical care services of relevance to this low-income country

sj-docx-1-mcr-10.1177_10775587231204101 – Supplemental material for Impact of the COVID-19 Pandemic on the Community Pharmacy Workforce

Supplemental material, sj-docx-1-mcr-10.1177_10775587231204101 for Impact of the COVID-19 Pandemic on the Community Pharmacy Workforce by Jennifer L. Bacci, Samantha W. Pollack, Susan M. Skillman, Peggy Soule Odegard, Jennifer Hookstra Danielson and Bianca K. Frogner in Medical Care Research and Review</p